≥6 years
Showing 9976 - 10000 of >10,000
Safety of a Single Dose of COMVIGEN Vaccine, Reactogenicity of a Single Dose of COMVIGEN Vaccine, Immunogenicity of a Single
Not yet recruiting
- Safety of a Single Dose of COMVIGEN Vaccine
- +5 more
- Comvigen (Bivalent, ChulaCov19 BNA159.2)
- BIVALENT Pfizer/BNT vaccine
-
Bangkok, Thailand
- +1 more
Jun 29, 2023
Bipolar Disorder, Psychosocial Intervention Trial in Ann Arbor (Mobile intervention)
Completed
- Bipolar Disorder
- Psychosocial Intervention
- Mobile intervention
-
Ann Arbor, MichiganUniversity of Michigan
Dec 2, 2021
Lung Cancer, Nonsmall Cell Trial (Pembrolizumab, Carboplatin, Paclitaxel)
Not yet recruiting
- Lung Cancer, Nonsmall Cell
- Pembrolizumab
- +3 more
- (no location specified)
May 7, 2021
Neurofibromatosis 1, Noonan Syndrome, Legius Syndrome Trial run by the National Cancer Institute (NCI) (Waitlist, ACT
Recruiting
- Neurofibromatosis 1
- +4 more
- Waitlist
- ACT Intervention
-
Bethesda, MarylandNational Cancer Institute (NCI)
Feb 2, 2023
Aortic Valve Disease, Aortic Valve Disorder Trial in Worldwide (Trifecta GT (Glide Technology) Valve)
Active, not recruiting
- Aortic Valve Disease
- Aortic Valve Disorder
- Trifecta GT (Glide Technology) Valve
-
Rochester, Minnesota
- +26 more
Mar 10, 2022
Helicobacter Pylori Infection Trial in Jinan (10-day Tegoprazan bismuth-containing quadruple therapy)
Not yet recruiting
- Helicobacter Pylori Infection
- 10-day Tegoprazan bismuth-containing quadruple therapy
-
Jinan, Shandong, ChinaQilu hosipital
Feb 1, 2023
Gut Microbiome on Metabolic and Bowel Function During First Year
Not yet recruiting
- Spinal Cord Injuries
- Gut Microbiome
- Gut Microbiome
-
Birmingham, AlabamaThe University of Alabama at Birmingahm
Dec 20, 2022
Prostate Cancer With =10 Bone Metastases Trial (Apalutamide, 89Sr, Luteinizing Hormone-Releasing Hormone Analog)
Not yet recruiting
- Prostate Cancer With ≤10 Bone Metastases
- Apalutamide
- +2 more
- (no location specified)
Feb 22, 2023
Myopia, Progressive Trial in Shanghai (Photobiomodualtion Therapy, Single vision spectacles for correction myopia)
Recruiting
- Myopia, Progressive
- Photobiomodualtion Therapy
- Single vision spectacles for correction myopia
-
Shanghai, Shanghai, ChinaEye & ENT hospital of Fudan university
Mar 7, 2023
Biology of Skin Neurofibromas in Neurofibromatosis Type 1
Completed
- Neurofibromatosis Type 1
- Neurofibroma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Sarcopenia Trial in Orléans (Dual-energy X-ray absorptiometry)
Not yet recruiting
- Sarcopenia
- Dual-energy X-ray absorptiometry
-
Orléans, FranceCHR d'Orléans
May 11, 2023
Breast Cancer, HER2-positive Breast Cancer Trial in Zhengzhou (Albumin paclitaxel+trastuzumab+pyrrolitinib,
Active, not recruiting
- Breast Cancer
- HER2-positive Breast Cancer
- Albumin paclitaxel+trastuzumab+pyrrolitinib
- Docetaxel+Carboplatin+trastuzumab+Parstuzumab
-
Zhengzhou, Henan, ChinaHenan cancer hospital
Jun 23, 2023
Ischemic Stroke, Atherosclerosis Trial in Dublin (Colchicine 0.5 MG)
Not yet recruiting
- Ischemic Stroke
- Atherosclerosis
- Colchicine 0.5 MG
-
Dublin, IrelandStroke Clinical Trials Network Ireland
Sep 25, 2023
Respiratory Distress Syndrome Trial in Evanston (MIST surfactant)
Not yet recruiting
- Respiratory Distress Syndrome
- MIST surfactant
-
Evanston, IllinoisNorthshore University Healthsystem
Sep 27, 2023
Cardiovascular Diseases, Metabolic Syndrome Trial in Loveland (Healthy Hearts Family Program)
Recruiting
- Cardiovascular Diseases
- Metabolic Syndrome
- Healthy Hearts Family Program
-
Loveland, ColoradoMedical Center of the Rockies
Sep 27, 2022
Deep Vein Thrombosis, Venous Thromboembolism Trial in Worldwide (Edoxaban low dose, Edoxaban high dose)
Completed
- Deep Vein Thrombosis
- Venous Thromboembolism
- Edoxaban low dose
- Edoxaban high dose
-
Los Angeles, California
- +34 more
Jan 18, 2022
Early Breast Lesions
Not yet recruiting
- Breast Cancer
- Nanomechanical Phenotype Test
-
Houston, TexasBaylor College of Medicine
Oct 10, 2023
Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)
Recruiting
- Neoplasms
- Solid Tumors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Intrahepatic Cholangiocarcinoma Trial in Padova (Liver transplantation)
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Liver transplantation
-
Padova, ItalyAzienda Ospedale Università di Padova
Oct 25, 2023
Adverse Effect Trial (Hydroxyethyl starch 130/0.4)
Not yet recruiting
- Adverse Effect
- Hydroxyethyl starch 130/0.4
- (no location specified)
Jul 26, 2022
COPD, Emphysema, Emphysema or COPD Trial (dual anti-platelet therapy, Placebo)
Not yet recruiting
- COPD
- +2 more
- dual anti-platelet therapy
- Placebo
- (no location specified)
Oct 9, 2022
COVID-19 Trial in Worldwide (CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Placebo; 0.9% saline, SCB-2019 vaccine)
Recruiting
- COVID-19
- CpG 1018/Alum-adjuvanted SCB-2019 vaccine
- +3 more
-
Alken, Belgium
- +30 more
Feb 7, 2022
Jaw, Edentulous Trial in Mansoura (Maxillary screw-retained prosthesis)
Completed
- Jaw, Edentulous
- Maxillary screw-retained prosthesis
-
Mansoura, EgyptDelta University for Science & Technology
Jan 31, 2023
Fatigue, Cancer, Physical Activity Trial in Heidelberg (Exercise - Social Media, Exercise - App, Exercise - closed to patients
Completed
- Fatigue
- +3 more
- Exercise - Social Media
- +2 more
-
Heidelberg, Baden-Wuerttemberg, GermanyNational Center for Tumor Diseases
Nov 4, 2022